MD Medical, the entity overseeing the Mat' I Ditya clinics chain, is making moves to secure a primary listing status on the Moscow Exchange. The healthcare provider has submitted its strategy, including registering its Global Depository Receipts (GDRs) with the Bank of Russia, aiming to ensure no additional burden falls upon its GDR holders.
The company's GDRs have been listed on the Moscow Exchange since 2020 and were also listed on the London Stock Exchange (LSE) in 2012. However, they were delisted from LSE in 2023 due to trading suspension. MD Medical reassures that despite these changes, the GDRs will continue to be traded in Moscow and remain as "tradable assets" within the regulated market of the Moscow Exchange.
While awaiting the Bank of Russia's decision on public circulation of its GDRs within established legal timeframes, MD Medical guarantees that no further actions are required from GDR holders.
MD Medical holds a significant position in Russia's healthcare sector with a vast network of 53 medical facilities, including hospitals and outpatient centers spread across various regions in Russia. The company's extensive reach underlines its major contribution to providing healthcare services across the nation.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.